• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. SENOMARK ULTRACOR MARKER; BREAST TISSUE MARKER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. SENOMARK ULTRACOR MARKER; BREAST TISSUE MARKER Back to Search Results
Model Number SMUC10H
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Reaction, Injection Site (2442)
Event Date 08/28/2017
Event Type  Injury  
Manufacturer Narrative
Manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.This is the only complaint reported to date for this lot number and failure mode.Investigation summary: the sample was not returned for evaluation.Therefore, the investigation is inconclusive for the reported reaction issue.Per the reported event details, the patient stated she has not been able to wear metal jewelry for years however no confirmation of any allergies was provided.Per the instructions for use, the device contains a resorbable polyglycolic acid (pga) pad, one biodur 108 wireform, and one interwoven polyvinyl alcohol (pva) polymer.Additionally, the ifu states, "patients with a known hypersensitivity to the materials listed in the device description may suffer an allergic reaction to this implant".Therefore it is likely patient factors contributed to this event.However, based upon the available information, the definitive root cause is unknown.Labeling review: the current senomark ultracor breast tissue marker instructions for use (ifu) state: general information and device description: -the marker contains a resorbable polyglycolic acid (pga) pad with a wireform that includes an interwoven polyvinyl alcohol (pva) polymer for permanent ultrasound enhancement.The pga pad is essentially resorbed in approximately 12 weeks.Please note the pva polymer is not resorbed.Contraindications: -patients with a known hypersensitivity to the materials listed in the device description may suffer an allergic reaction to this implant.Warnings: -do not use in the presence of infection.-this device has been designed for single use only.Reuse of this device bears the risk of cross-patient contamination, as medical devices with long and small lumina, joints, and/or crevices between components are difficult or impossible to clean.The residue of biological material can promote the contamination of the device with pyrogens or microorganisms which may lead to infectious complications.Precautions: this product should only be used by a physician who is completely familiar with the indications, contraindications, limitations, typical findings and possible side effects of breast tissue marker placement.Potential complications: -complications may occur at any time during or after the procedure.Potential complications of breast tissue marker placement may include, but are not limited to hematoma, hemorrhage, infection, adjacent tissue injury and pain.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event Description
It was reported that post breast tissue marker placement, the patient allegedly may have a hematoma and is experiencing itching, swelling, and warmth at the injection site.The physician was advised and started the patient on antibiotics.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SENOMARK ULTRACOR MARKER
Type of Device
BREAST TISSUE MARKER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
INFUS MEDICAL (THAILAND)
706 moo 4
bangpoo ind estate
samutprakarn province 10280
TH   10280
Manufacturer Contact
judith ludwig
1625 w 3rd st.
tempe, AZ 85281
4803032689
MDR Report Key6913887
MDR Text Key88139319
Report Number2020394-2017-01274
Device Sequence Number1
Product Code NEU
UDI-Device Identifier00801741032394
UDI-Public(01)00801741032394
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K050090
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,consum
Reporter Occupation Physician
Type of Report Initial
Report Date 10/04/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/04/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/01/2020
Device Model NumberSMUC10H
Device Catalogue NumberSMUC10H
Device Lot NumberVTBQ00110
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/06/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/23/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age51 YR
Patient Weight76
-
-